Ignite Creation Date:
2024-05-05 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00141128
Status:
COMPLETED
Last Update Posted:
2011-06-01
First Post:
2005-08-29
Brief Title:
Evaluation Of A Novel Methodology In The Assessment Of Urethral Function Using SS-RBX
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
Measurement Of Urethral Function In Women With Stress Urinary Incontinence - Evaluation Of The Sensitivity Of Urethral Reflectometry Compared To Urethral Pressure Profilometry Using SS-Reboxetine To Detect Pharmacological Augmentation Of Urethral Pressure
Status:
COMPLETED
Status Verified Date:
2011-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
SS-RBX will be used to evaluate pharmacodynamic changes in urethral function using a novel methodology
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None